Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederfiercebiotech.com
FierceBiotech
Get the latest updates from FierceBiotech directly as they happen.
Follow now 328 followers
Latest posts
Last updated 2 days ago
Roche’s Genentech cut at least 489 jobs last year, new disclosure reveals
2 days ago
On top of 348 known job cuts across the organization last year...
UniQure pauses Fabry gene therapy dosing in 2 groups after toxicities emerge
2 days ago
Two dose-limiting toxicities have been recorded in uniQure’s trial evaluating an investigational...
Medtronic hit with $382M antitrust ruling over surgical device monopoly
2 days ago
Applied Medical has been awarded $382 million in damages from Medtronic after...
Qiagen 'open for discussion' on shareholder value, but CEO stays mum on takeover talk
2 days ago
Qiagen’s outgoing chief executive Thierry Bernard, M.D., told investors the company does...
Chutes & Ladders—Moderna CMO steps down in leadership mix-up
2 days ago
Moderna Chief Medical Officer Jacqueline Miller, M.D., is stepping down after a...
Pfizer-backed Priovant scores again with fast-rising brepocitinib in midstage study
2 days ago
As Priovant works toward approval of potential blockbuster brepocitinib as a treatment...
NICE greenlights Abbott's cardiac sensor implant for NHS
2 days ago
Abbott’s wireless, paperclip-sized cardiac sensor has received the blessing of the National...
Agomab, SpyGlass head to Nasdaq with IPOs totalling $350M
2 days ago
Belgian biotech Agomab Therapeutics and eye-focused drug delivery company SpyGlass Pharma both...
How AI Is reshaping clinical trials and market access
3 days ago
H1 CEO Ariel Katz shares how AI, regulation and pricing shifts are...
The Data Multiplier Effect: When Expertise, Monitoring, Systems, and AI Align
3 days ago
Trial oversight is shifting from reactive checks to continuous signal detection. Here’s...
Racing BMS and J&J, Bayer links asundexian to 26% stroke reduction to unblock path to FDA
3 days ago
Bayer has linked asundexian to a 26% reduction in stroke in a...
Astellas tops expectations as Vyloy sales surge outshines trial setback
3 days ago
Astellas surpassed market expectations in its third-quarter fiscal year 2025 results, as...